🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

3,061 results for “Bio” Clear

  1. brand name metoprolol ER

    BRIGHT MINDS BIOSCIENCES INC.

    Blood Pressure

    approved small molecule completed

    1 trial

  2. buprenorphine/naloxone

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    approved small molecule active

    3 trials

  3. bupropion SR

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco-Use Disorder

    approved small molecule completed

    1 trial

  4. combination NRT

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    approved small molecule completed

    1 trial

  5. counseling

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    approved other completed

    1 trial

  6. counseling

    BRIGHT MINDS BIOSCIENCES INC.

    Amphetamine-Related Disorders

    approved other active

    1 trial

  7. doxazosin plus tolterodine SR

    Samsung Bioepis NL B.V.

    Overactive Bladder

    approved small molecule completed

    1 trial

  8. fecal microbiota transplantation

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Ulcerative Colitis

    approved small molecule active

    1 trial

  9. hepatitis B vaccine made by Recombinant DNA Techniques in Saccharomyces Cerevisiae

    BRIGHT MINDS BIOSCIENCES INC.

    Hepatitis B Vaccines

    approved mab completed

    1 trial

  10. laronidase

    BioMarin Pharmaceutical Australia Pty Ltd

    Mucopolysaccharidosis I

    approved small molecule completed

    3 trials

  11. medication for opioid use disorder

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    approved small molecule completed

    1 trial

  12. methadone

    BRIGHT MINDS BIOSCIENCES INC.

    Heroin Dependence

    approved small molecule completed

    1 trial

  13. naltrexone for extended release injectable suspension

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    approved small molecule completed

    1 trial

  14. nicotine patch

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Dependence

    approved small molecule completed

    2 trials

  15. rhGM-CSF group

    Biotech Pharmaceutical Co.,

    Mycoses

    approved small molecule completed

    1 trial

  16. sIPV+DTaP+MMR

    BRIGHT MINDS BIOSCIENCES INC.

    Vaccine

    approved mab active

    1 trial

  17. saproterin dihydrochloride

    BioMarin Pharmaceutical Australia Pty Ltd

    Phenylketonuria

    approved small molecule completed

    1 trial

  18. sublingual nicotine

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    approved small molecule completed

    1 trial

  19. transdermal nicotine replacement therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking

    approved small molecule active

    1 trial

  20. umeclidinium 62.5 µg and vilanterol 25 µg

    Theravance Biopharma Ireland Umited

    COPD (Chronic Obstructive Pulmonary Disease)

    approved small molecule active

    1 trial

  21. varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Cigarette Smoking

    approved small molecule completed

    2 trials

  22. zyban

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    approved small molecule completed

    1 trial

  23. 10% N2O

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-Related Disorders

    small molecule completed

    1 trial

  24. 11UCB-J PET Scan

    BRIGHT MINDS BIOSCIENCES INC.

    Opiate Dependence

    other completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources